PROVIDENCE, R.I.--(BUSINESS WIRE)--Tivorsan Pharmaceuticals, Inc., a privately held biotechnology company developing a novel protein therapeutic to combat Duchenne Muscular Dystrophy (DMD), has been selected as one of 2011’s Windhover’s Top 10 Most Interesting “Hot Space” Projects to Watch.
